509-38-6 Usage
Uses
Used in Pharmaceutical Industry:
(16xi,17R,19E)-ajmal-19-en-17-ol is used as a pharmaceutical compound for its potential antiarrhythmic and anti-inflammatory effects. Its specific stereochemistry may contribute to its biological activity, making it a promising candidate for further research and development in the pharmaceutical field.
Further research is needed to fully understand the functions and potential uses of this chemical compound, as well as to explore its potential applications in other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 509-38-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,0 and 9 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 509-38:
(5*5)+(4*0)+(3*9)+(2*3)+(1*8)=66
66 % 10 = 6
So 509-38-6 is a valid CAS Registry Number.
509-38-6Relevant academic research and scientific papers
Stereoselective Transformation of Ajmaline into Three Minor Gelsemium Alkaloids, Koumidine, (19Z)-Anhydrovobasinediol and N-Demethoxyrankinidine and their Absolute Configuration
Kitajima, Mariko,Takayama, Hiromitsu,Sakai, Shin-ichiro
, p. 1773 - 1779 (2007/10/02)
Ajmaline was converted into new Gelsemium alkaloids, 19Z-anhydrovobasinediol and N-demethoxyrankinidine, via koumidine along the biomimetic sequence, and the absolute configuration of these alkaloids was determined by these transformations.
Partial Synthesis and the Absolute Configuration of Two New Gelsemium Alkaloids, Koumidine and (19Z)-Taberpsychine
Takayama, Hiromitsu,Kitajima, Mariko,Wongseripipatana, Sumphan,Sakai, Shin-ichiro
, p. 1075 - 1076 (2007/10/02)
The stereoselective transformation of ajmaline (3) into a new Gelsemium alkaloid, (19Z)-taberpsychine (1), via koumidine (2) is described.